Atomoxetine Press Articles

Clinical Psychiatry News - ADHD drug studied for first time in 5-year-olds

May 1, 2011 --

Atomoxetine was generally well tolerated and resulted in reduced core attention-deficit/hyperactivity disorder symptoms in a study of 101 5-...

continue reading

Townsend Letter - Healing with homeopathy: treating psychic and spiritual children with homeopathic medicine

February 1, 2011 --

An Engaging Child with a Big Heart

Diego's mother described him as a fun character. He was 10 years old - a fourth-grader with a...

continue reading

Drug Store News - The Food and Drug Administration has approved a generic drug made by Actavis for treating attention deficit hyperactivity disorder, Actavis said

September 27, 2010 --

The Food and Drug Administration has approved a generic drug made by Actavis for treating attention deficit hyperactivity disorder, Actavis...

continue reading

MondayMorning - FDA roundup: Aurobindo Pharma Ltd

September 20, 2010 --

FDA ROUNDUP: Aurobindo Pharma Ltd. (Hyderabad IND) received final approval for atomoxetine hydrochloride in capsule form. The capsules, which...

continue reading

Business Wire - Sun Pharma Announces USFDA Approval for Generic Strattera® Capsules

August 1, 2010 -- Sun Pharma announces USFDA approval for generic Strattera® Capsules;Company receives 180 days marketing exclusivity

Published on Saturday 26th of May 2012 04:47:17 AM

continue reading

Business Wire - Hayes Evaluates Test and Treatment Options for Attention-Deficit Hyperactivity Disorder

August 19, 2008 -- More clinical research needed to recommend most ADHD treatments

More clinical research needed to recommend most ADHD treatments

...

continue reading

Chain Drug Review - FDA grants approval to Eli Lilly's Strattera

June 30, 2008 -- INDIANAPOLIS -- Eli Lilly and Co. has received Food and Drug Administration clearance for Strattera (atomoxetine HCl) for maintenance treatment of...

continue reading

Pediatric News - Strattera

June 1, 2008 -- Strattera (atomoxetine HCl, Eli Lilly & Co.)

Strattera (atomoxetine HCl, Eli Lilly & Co.)

The Food and Drug Administration...

continue reading

Clinical Psychiatry News - Atomoxetine OK'd for ADHD maintenance

June 1, 2008 -- "The Pink Sheet"

"The Pink Sheet"

The Food and Drug Administration has approved nonstimulant atomoxetine as a...

continue reading

Market Wire - FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents

May 8, 2008 --

Eli Lilly and Company (NYSE: LLY) announced today that the United States Food and Drug Administration (FDA) has approved Strattera®...

continue reading